Relevance of Hu 2026 BRCA2 functional-integration classification yield to "Interpret BRCA1/BRCA2 germline variants"
- Use case
- Interpret BRCA1/BRCA2 germline variants
- Assessed by
- Hu 2026 BRCA2 functional-integration classification yield
- Relevance
- Proxy evidence
- Endpoint
- Fraction of 6,383 BRCA2 exon 15-26 single-nucleotide variants reaching a final pathogenic/likely pathogenic or benign/likely benign classification using combined saturation-genome-editing functional-data evidence (Integrated VarCall model) under the ENIGMA BRCA1/BRCA2 VCEP specification
A functional-data classification yield/coverage figure for a combined SGE assay model applied to a single BRCA2 domain; it measures how many variants reach a final call under integrated functional evidence, not independent clinical accuracy and not a complete professional classification review.
1 reviewed evaluation
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
15 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints1 values
| Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint Fraction of 6,383 BRCA2 exon 15-26 single-nucleotide variants reaching a final pathogenic/likely pathogenic or benign/likely benign classification using combined saturation-genome-editing functional-data evidence (Integrated VarCall model) under the ENIGMA BRCA1/BRCA2 VCEP specification Context-only references | Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:uc-clinical-20261005-hu-2026-protocol Context-only references | Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations3 values
| Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records5 values
| Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale A functional-data classification yield/coverage figure for a combined SGE assay model applied to a single BRCA2 domain; it measures how many variants reach a final call under integrated functional evidence, not independent clinical accuracy and not a complete professional classification review. Context-only references | Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Reason Add independently checked primary-source protocol evidence from the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343); scope the endpoint to functional-data classification yield in BRCA2 exons 15-26, not full professional review. Context-only references | Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relevance proxy Context-only references | Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Revision 1 Context-only references | Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications Version: 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-adc15377fab2 · Record review: source checked
1 source record and release history
- Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification · Original source · 2026 published article (Nature Communications), published 2026-04-09; ENIGMA BRCA1/BRCA2 VCEP specification v1.2.0 applied
Technical metadata and extraction receipts
Stable ID: use-case-mapping-20261005-343-4d6887d8d2e1
- field
- links:assessed_by:uc-clinical-20261005-hu-2026-protocol
- value
- uc-clinical-20261005-hu-2026-protocol
- relevance
- proxy
- endpoint
- Fraction of 6,383 BRCA2 exon 15-26 single-nucleotide variants reaching a final pathogenic/likely pathogenic or benign/likely benign classification using combined saturation-genome-editing functional-data evidence (Integrated VarCall model) under the ENIGMA BRCA1/BRCA2 VCEP specification
- rationale
- A functional-data classification yield/coverage figure for a combined SGE assay model applied to a single BRCA2 domain; it measures how many variants reach a final call under integrated functional evidence, not independent clinical accuracy and not a complete professional classification review.
- constraints
- 6,383 BRCA2 single-nucleotide variants, exons 15-26 (C-terminal DNA-binding domain) only; not representative of the full gene or of BRCA1.
- limitations
- Classification yield/coverage using an integrated functional-data proxy, not independent clinical accuracy and not a complete professional classification review.; BRCA2 only, limited to exons 15-26; matched six-model comparator panels and all per-model sensitivity/specificity figures are not used in this mapping.; No reviewer time or independent clinical adjudication reported.
- revision
- 1
- reason
- Add independently checked primary-source protocol evidence from the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343); scope the endpoint to functional-data classification yield in BRCA2 exons 15-26, not full professional review.
- citation locators
- source id: uc-clinical-20261005-source-hu-2026; locator: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications
- source locator
- uc-clinical-20261005-source-hu-2026: Results, Incorporation of the Integrated VarCall model functional data into the BRCA1/2 ClinGen variant classification specifications
- review
- method: automated-source-review; reviewer: claude-sonnet; reviewer note: Claude Sonnet clinical coverage worker (research-evidence intake), root integration review; reviewed at: 2026-10-05T17:39:47.679Z; note: Source-backed literature curation with independent automated transcription and scope checks against the additive 2026-10-05 BRCA1/BRCA2 evidence intake (issue #343). No new model execution, independent experimental replication, qualified human scientific review or clinical validation.
- reviewed evaluations
- uc-clinical-20261005-hu-2026-evaluation
- pins
- record id: uc-clinical-20261005-hu-2026-classified-yield; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: af57ab421955337a18cc1e7703109f40bb8a9e2e81c66c444ff9af3bf06833d9; record id: uc-clinical-20261005-hu-2026-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: bbea687e9bc903854a251bec46f240343cadb83ac8f6465c054254721bc54359; record id: uc-clinical-20261005-hu-2026-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: 7eca34f4656b5a813fce8478dce32a5fa4d33ddd5d00b933fa239afb60809d0b; record id: uc-clinical-20261005-source-hu-2026; fields: status; attributes.artifact_sha256; sha256: 7bc108e894bc2cfbf1c9e39c531e7223b202d2bc05d45ede9a6bff350c0e942d; record id: use-case-brca1-brca2-germline-interpretation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd